Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Total Equity

Arbutus Biopharma Cp Total Equity Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Total Equity from 2010 to 2018.
  • Arbutus Biopharma Cp Total Equity for the quarter ending December 12, 2018 was $200m a -16.09% decrease of -32m year over year
  • Arbutus Biopharma Cp Total Equity for the last 12 months ending December 12, 2018 was $200m a -16.09% decrease of -32m year over year
  • Arbutus Biopharma Cp Annual Total Equity for 2018 was $200m a 8.84% increase of 18m from 2017
  • Arbutus Biopharma Cp Annual Total Equity for 2017 was $183m a -11.24% decrease of -21m from 2016
  • Arbutus Biopharma Cp Annual Total Equity for 2016 was $203m a -169.79% decrease of -345m from 2015
Other Balance Sheet Metrics:
  • Arbutus Biopharma Cp Total Assets for the quarter ending December 12, 2018 was $228m a -18.48% decrease of -42m year over year
  • Arbutus Biopharma Cp Other Liabilities for the quarter ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
View Chart On Koyfin

Quarterly ABUS Total Equity Data

12/2018$200m
09/2018$215m
06/2018$238m
03/2018$232m
12/2017$182m
09/2017$167m
06/2017$176m
03/2017$189m
12/2016$203m
09/2016$417m

Annual ABUS Total Equity Data

2018$200m
2017$183m
2016$203m
2015$548m
2014$88m
2013$59m
2012$41m
2011$5m
2010$11m
2009$21m